• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

IVI Research Brief Uses Patient Insights as Foundation for Value

Article

A research brief from the Innovation and Value Initiative (IVI) sought to determine how metastatic non-small lung cancer patients’ perspectives and experiences shape cancer-related treatment decisions.

A research brief from the Innovation and Value Initiative (IVI) sought to determine how metastatic non-small lung cancer (NSCLC) patients’ perspectives and experiences shape cancer-related treatment decisions. IVI constructed in-depth interviews and focus groups with patients with metastatic NSCLC to gain insight into their perspectives on disease burden and treatment.

The research brief identified several broad themes including the need to make frequent trade-offs in treatment decisions and urgency created by the metastatic nature of disease. Patients also identified specific determinants of value in their treatment experience, including personalized care and treatments that offer tolerable side effects.

Read the full research brief.

Related Videos
Dr Margrit Wiesendanger
Ibrahim Aldoss, MD, associate professor, City of Hope
Manmeet Ahluwalia, MD, MBA, FASCO, chief of medical oncology, chief scientific officer, and deputy director of the Miami Cancer Institute of Baptist Health South Florida
Cathy Eng, MD, FACP, FASCO
Dr Margrit Wiesendanger
Nini Wu, MD, Navista
Fred Locke, MD, Moffitt Cancer Center and Research Institute
Dr Margrit Wiesendanger
Tom Belmon, CAP, GPBCH
Tom Belmont
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.